BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs6983267
,
SLC12A1
,
T cell receptor signaling pathway
,
Diabetes mellitus
,
Lung
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
early prostate cancer antigen, human
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Carcinoma of prostate PC3 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Non-small cell lung cancer HCC515 cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Serum early prostate cancer antigen (EPCA) level and its association with disease progression in pro…
Preoperative serum levels of early prostate cancer antigen (EPCA) predict prostate cancer progressio…
Serum early prostate cancer antigen (EPCA) as a significant predictor of incidental prostate cancer …
Increased serum level of early prostate cancer antigen is associated with subsequent cancer risk in …
Biotechnology. Researcher, two universities sued over validity of prostate cancer test.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study of NanoKnife for Ablation of Prostate Cancer in Intermediate Risk Patients
GVAX in Advanced Prostate Cancer Patients Made Lymphopenic
A Neoadjuvant Study of Androgen Ablation Combined With Cyclophosphamide and GVAX Vaccine for Localiz…
MR-US Image Fusion Targeted Biopsy for Single-cell Prostate Cancer Research
Rucaparib and Nivolumab in Patients With Prostate or Endometrial Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ